Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16452469
[patent_doc_number] => 20200361895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/638698
[patent_app_country] => US
[patent_app_date] => 2018-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638698 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | Aug 14, 2018 | Pending |
Array
(
[id] => 16792922
[patent_doc_number] => 20210122739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/638704
[patent_app_country] => US
[patent_app_date] => 2018-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638704 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | Aug 14, 2018 | Pending |
Array
(
[id] => 17193085
[patent_doc_number] => 11161825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides
[patent_app_type] => utility
[patent_app_number] => 16/638683
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21498
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638683 | 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides | Aug 8, 2018 | Issued |
Array
(
[id] => 13826407
[patent_doc_number] => 20190016688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/100193
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100193 | DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS | Aug 8, 2018 | Abandoned |
Array
(
[id] => 16483904
[patent_doc_number] => 20200377505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/636606
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -101
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636606 | BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES, AND METHODS OF USE THEREOF | Aug 2, 2018 | Pending |
Array
(
[id] => 16468115
[patent_doc_number] => 20200369652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => PROCESSES FOR PREPARATION OF LIFITEGRAST AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/636212
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636212 | PROCESSES FOR PREPARATION OF LIFITEGRAST AND INTERMEDIATES THEREOF | Aug 1, 2018 | Abandoned |
Array
(
[id] => 16807770
[patent_doc_number] => 20210130323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => FORMYLPYRIDINE DERIVATIVE HAVING FGFR4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/633254
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633254
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633254 | Formylpyridine derivative having FGFR4 inhibitory activity, preparation method therefor and use thereof | Jul 31, 2018 | Issued |
Array
(
[id] => 14731399
[patent_doc_number] => 10385089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Thionucleoside derivative or salt thereof, and pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 16/037375
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28878
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 458
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16037375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/037375 | Thionucleoside derivative or salt thereof, and pharmaceutical composition | Jul 16, 2018 | Issued |
Array
(
[id] => 16060837
[patent_doc_number] => 10689350
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-06-23
[patent_title] => Method for preparation of chlorinated s-propylthiobarbituric acid
[patent_app_type] => utility
[patent_app_number] => 16/621222
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2155
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621222 | Method for preparation of chlorinated s-propylthiobarbituric acid | Jul 15, 2018 | Issued |
Array
(
[id] => 13533525
[patent_doc_number] => 20180318305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/035774
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16035774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/035774 | COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES | Jul 15, 2018 | Abandoned |
Array
(
[id] => 14005453
[patent_doc_number] => 10221162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Triazole agonists of the APJ receptor
[patent_app_type] => utility
[patent_app_number] => 16/033632
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 184533
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1001
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033632
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/033632 | Triazole agonists of the APJ receptor | Jul 11, 2018 | Issued |
Array
(
[id] => 14422453
[patent_doc_number] => 10316016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Compositions comprising an inhibitor of lysine specific demethylase-1
[patent_app_type] => utility
[patent_app_number] => 16/032002
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10104
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16032002
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/032002 | Compositions comprising an inhibitor of lysine specific demethylase-1 | Jul 9, 2018 | Issued |
Array
(
[id] => 16072161
[patent_doc_number] => 20200190067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PHOTO-SWITCHABLE CHEMICAL INDUCERS OF DIMERIZATION FOR CONTROL OF PROTEIN FUNCTION IN CELLS BY LIGHT
[patent_app_type] => utility
[patent_app_number] => 16/628729
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 583
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628729 | PHOTO-SWITCHABLE CHEMICAL INDUCERS OF DIMERIZATION FOR CONTROL OF PROTEIN FUNCTION IN CELLS BY LIGHT | Jul 5, 2018 | Abandoned |
Array
(
[id] => 15970107
[patent_doc_number] => 20200168805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/632009
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632009
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632009 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Jul 1, 2018 | Pending |
Array
(
[id] => 16156423
[patent_doc_number] => 20200216444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => CRYSTAL FORM AND SALT FORM OF N-PHENYL-2-AMINOPYRIMIDINE COMPOUND, AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/631276
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631276 | Crystal form and salt form of | Jun 28, 2018 | Issued |
Array
(
[id] => 13507561
[patent_doc_number] => 20180305323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => Prolyl Hydroxylase Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/023058
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023058 | Prolyl hydroxylase inhibitors | Jun 28, 2018 | Issued |
Array
(
[id] => 17421213
[patent_doc_number] => 11254654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Heterochromatin gene repression inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/622073
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 41511
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622073 | Heterochromatin gene repression inhibitors | Jun 28, 2018 | Issued |
Array
(
[id] => 13777813
[patent_doc_number] => 20190002445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => PROCESS FOR PREPARING LIFITEGRAST AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/023580
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023580
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023580 | Process for preparing lifitegrast and intermediates thereof | Jun 28, 2018 | Issued |
Array
(
[id] => 13507559
[patent_doc_number] => 20180305322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
[patent_app_type] => utility
[patent_app_number] => 16/021415
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16021415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/021415 | Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith | Jun 27, 2018 | Issued |
Array
(
[id] => 15160657
[patent_doc_number] => 10485801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Pyrimidinyl-diazospiro compounds
[patent_app_type] => utility
[patent_app_number] => 16/019886
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14636
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16019886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/019886 | Pyrimidinyl-diazospiro compounds | Jun 26, 2018 | Issued |